Does TRAVOPROST Cause Neoplasm malignant? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm malignant have been filed in association with TRAVOPROST (Travoprost Ophthalmic Soluton). This represents 0.3% of all adverse event reports for TRAVOPROST.
18
Reports of Neoplasm malignant with TRAVOPROST
0.3%
of all TRAVOPROST reports
0
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm malignant From TRAVOPROST?
Of the 18 reports, 3 (16.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAVOPROST. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TRAVOPROST Cause?
Treatment failure (2,364)
Ocular hyperaemia (478)
Drug ineffective (467)
Eye irritation (448)
Intraocular pressure increased (335)
Hypersensitivity (305)
Glaucoma (286)
Eye pain (284)
Visual impairment (264)
Vision blurred (180)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TRAVOPROST Alternatives Have Lower Neoplasm malignant Risk?
TRAVOPROST vs TRAZODONE
TRAVOPROST vs TREANDA
TRAVOPROST vs TREMELIMUMAB
TRAVOPROST vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TRAVOPROST vs TRENBOLONE